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Genomes of TT virus (TTV) and TTV-like minivirus DNA were detected in 80% and 61% of cervical swabs
from healthy women, respectively, regardless of concurrent human papillomavirus infection. These results
show that the potential exists for sexual transmission of TTV and related viruses.
TT virus (TTV) is a recently described DNA virus of humans
that shows a number of unusual properties (9, 11). From the
clinical microbiology standpoint, a most remarkable feature of
TTV is its widespread presence in the blood of infected indi-
viduals—often at high titers and for prolonged or indefinite
periods of time—in the apparent total absence of associated
pathological effects (1). For example, in recent studies of the
general population of Tuscany, Italy, the prevalence of subjects
who carry TTV in the blood was on the order of 90%, and
viremia loads ranged between 7.7 3 102 and 6.2 3 108 DNA
copies per ml of plasma, as determined with an open reading
frame 1-targeted real-time PCR assay (8, 12). Similarly high
prevalence rates have been reported from other countries,
whenever detection methods of comparable sensitivity were
used (5, 10). Thus, two aspects of TTV biology appear espe-
cially intriguing: the routes of interindividual transmission that
permit such a dissemination and the type(s) of relationship
with the infected organism that permits TTV to replicate ex-
tensively with no apparent damage to the host. A clear under-
standing of the body sites where TTV dwells and persists can
help shed light on both of these aspects.
Here we examined for the presence of TTV DNA 50 con-
secutive cervical swabs sent to our laboratory for human pap-
illomavirus (HPV) testing between October 1999 and May
2000. The specimens were collected from apparently healthy
women using routine procedures for prophylactic screening of
cervical cancer. Tests were performed without knowledge of
cytology and clinical data. Each swab was soaked and vortexed
gently in sterile phosphate-buffered saline, which was then
stored in aliquots at 270°C until use. HPV detection and
genotyping were carried out by amplifying a segment of the L1
gene with consensus primers MY09 and MY11 and subsequent
restriction fragment length polymorphism analysis, as reported
previously (2). Thirty-eight swabs were found to be HPV DNA
positive; of these, 20 carried low-risk HPV and 12 carried
high-risk HPV, while 6 HPV isolates were not typed (Table 1).
TTV detection was carried out using a TaqMan real-time
PCR assay (8, 12) that, being targeted to a highly conserved
segment of the nontranslated region (UTR) of the viral DNA,
detects a wider range of genotypes than most TTV detection
methods described to date, including the ones used by us in
previous studies (6). Forward and reverse primers were 59-G
TGCCGIAGGTGAGTTTA-39 (positions 177 to 194) and 59-
AGCCCGGCCAGTCC-39 (positions 226 to 239), respectively.
The probe was 59-TCAAGGGGCAATTCGGGCT-39 (posi-
tions 205 to 223), which was labeled with 6-carboxy-fluorescein
and 6-carboxy-tetramethyl-rhodamine at the 59 and 39 ends,
respectively, and had a propynilic group bound to each thymi-
dine to increase the annealing temperature. The procedures
used for quantification of copy numbers and evaluation of
intra- and interassay precision and reproducibility have been
previously described (12). Maximum intra- and interassay vari-
ation in the threshold cycle was about 3%, and specificity was
confirmed by repeatedly sequencing the products of amplifi-
cation. The lower limit of sensitivity of the assay was 1.0 3 103
copies/mg of DNA. All cervical swabs were tested in triplicate
twice from independent DNA extractions. Samples positive in
only one replicate or with a coefficient of variation of 50% or
greater constituted less than 2% of samples tested. These sam-
ples were reextracted and tested again in triplicate.
Nucleotide sequence accession numbers. Sequences of a
265-bp UTR segment from the TTV-like minivirus (TLMV)
isolates listed in Fig. 1 were submitted to GenBank (accession
no. AF312400 to AF312420).
The results of TTV testing are shown in Table 1. Overall,
80% of the cervical swabs examined were found positive, thus
indicating that TTV infection of the feminine genital tract is
extremely common in this select group of women. TTV loads
varied widely among individual samples, ranging between
1.3 3 103 and 1.7 3 108 copies per mg of total DNA. When the
swabs were grouped according to the results of HPV analysis,
TTV prevalence rates and titers were similar. Thus, although
the numbers of patients examined were too low to draw firm
conclusions, it would appear that TTV infection is not facili-
tated by concurrent HPV infection (Table 1).
While this study was in progress, Takahashi et al. (13) re-
ported on the existence of a new virus, related but clearly
distinct from TTV, in the plasma of Japanese voluntary blood
donors. Due to its small estimated size (less than 30 versus 30
to 50 nm) and shorter genome (approximately 2.9 versus 3.8
kb) relative to that of TTV, the virus was designated TLMV.
Early data have suggested that TLMV may be as widespread as
TTV, while modes of transmission and pathogenicity have yet
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to be investigated (13, 14). We tested 33 of the above-discussed
cervical swabs (27 TTV positive and 6 TTV negative) for the
presence of TLMV using a nested PCR assay targeted to a
segment of the UTR of the viral DNA, which, based on the
sequences available in gene banks at the time the assay was
developed, was well conserved and specific for TLMV. The
following oligonucleotide primers were used: external primers,
59-ATTTGAATTGCCGACCACA-39 (positions 30 to 48) and
59-CGCCAGACTGATCTAGCCCGAA-39 (positions 292 to
313); internal primers, 59-ATTGCCGACCACAAACTGAC
A-39 (positions 36 to 56) and 59-AGCCCGAATTGCCCCTA
GTC-39 (positions 280 to 300). Bands of the expected size (265
nucleotides [nt]) were detected in 20 samples (61%), regard-
less of concurrent infection with HPV (Table 1) and TTV (not
shown). Sequence alignment of 12 such bands with the
CLUSTALW program confirmed that they belonged to
TLMV, while phylogenetic relationships, estimated by using
DAMBE (version 4.0.9 [15]) and the neighbor-joining method,
showed a wide genetic heterogeneity (Fig. 1). TLMV isolates
detected in plasma samples have also been shown to be genet-
ically highly heterogeneous (13, 14). Interestingly, in addition
to the 265-nt TLMV bands, four cervical swabs yielded bands
of approximately 400 nt, which, when sequenced, were found
to belong to the YONBAN strain of TTV. This strain is cur-
rently grouped together with TTV, but its high degree of di-
vergence has led researchers to propose that it might represent
a separate viral species (14). Our TLMV primers had been
designed before UTR sequences of the YONBAN strain had
become available, but comparison with subsequently published
YONBAN sequences showed that the internal antisense
primer is highly conserved between TLMV and YONBAN.
This might explain why the TLMV PCR had permitted ampli-
fication of YONBAN virus from some swabs.
In conclusion, the present findings show that cervical spec-
imens may contain a wide array of TTV and related viruses.
Whether this reflects active replication of such viruses in the
female genital tract, for example by lymphoid cells (7), or
exudation from plasma remains to be established. Information
about sexual transmission of TTV and related viruses is scarce.
Recently, Inami et al. (4) detected TTV DNA in 6 of 10 human
semen samples tested. Together with the latter results, the
present data indicate that prerequisites exist for TTV and
related viruses being commonly transmitted via the sexual
route. Viral sequences obtained from sexual partners should
be compared in order to shed light on the importance of this
relative to other modes of transmission. Furthermore, in some
studies the high prevalence of TTV infections in infants was
attributed to close contact with infected mothers (3). Exposure
FIG. 1. Phylogenetic analysis of the TLMV isolates based on a
265-bp UTR segment (nt 36 to 300). Isolate NLC023 (13) was used as
an outgroup. The bar indicates the number of nucleotide substitutions
per site. The sequences from cervical swabs are marked with F, while
reference sequences are indicated by the isolate name only. Sequences
obtained in our laboratory from seven plasma samples (n ) and two
liver biopsy specimens () are also shown.
TABLE 1. Results of TTV and TLMV detection in cervical swabs, grouped by HPV DNA status
HPV status
Results
TTV TLMV
No. of samples tested No. (%) positive
Viral load (copies/mg of DNA)
No. of samples tested No. (%) positive
Range Mean (median)
HPV negative 12 10 (83) 1.6 3 104–7.2 3 106 2.5 3 106 (2.5 3 106) 7 5 (71)
HPV positive
Low riska 20 15 (75) 1.3 3 103–1.7 3 108 1.6 3 107 (1.2 3 106) 11 7 (64)
High riskb 12 9 (75) 1.0 3 104–5.1 3 107 7.2 3 106 (3.4 3 105) 11 6 (55)
Untypedc 6 6 (100) 6.6 3 105–6.8 3 106 2.5 3 106 (1.9 3 106) 4 2 (50)
Total 50 40 (80) 1.3 3 103–1.7 3 108 8.8 3 106 (1.4 3 106) 33 20 (61)
a Low-risk group includes HPV genotypes 6, 53, and 64.
b High-risk group includes HPV genotypes 16, 31, 33, 39, 52, and 58.
c Determination of HPV genotype was not done.
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to virus-containing vaginal fluids during delivery may contrib-
ute to perinatal transmission of these widespread viruses.
This work was supported in part by grants from the Ministero della
Universita` e Ricerca Scientifica.
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